For the Inventor, By the Inventor

Enter assignee name

Ridgefield, CT, United States of America

Boehringer Ingelheim Pharmaceuticals, Inc.

Calculating rank

USPTO Granted Patents = 278

% Expired Patents = 1.1

CIPO Patents = 15

EPO Patents = 11

Trademarks = 39

Forward Citations = 3,802

Loading Chart...

Loading Chart...

312 inventors (with patents filed for the assignee):

Eugene R Hickey (35 out of 66 patents)

John Robert Proudfoot (32 out of 38 patents)

David S Thomson (32 out of 46 patents)

4. Pier Francesco Cirillo (26 out of 33 patents)

5. Denice Mary Spero (24 out of 24 patents)

6. John R Regan (24 out of 51 patents)

7. Karl D Hargrave (24 out of 29 patents)

8. Neil Moss (23 out of 34 patents)

9. Sanxing Sun (22 out of 24 patents)

10. Weimin Liu (21 out of 46 patents)

11. Yancey David Ward (20 out of 21 patents)

12. Abdelhakim Hammach (18 out of 18 patents)

13. Charles Lawrence Cywin (18 out of 18 patents)

14. Daniel R Goldberg (17 out of 53 patents)

15. Usha R Patel (17 out of 17 patents)

Core Competencies:

Cytokine Inhibitors

Glucocorticoid Mimetics

Pyrimidine Derivatives

Antibodies

Stereoselective Synthesis

Fluorescent Probes

Cathepsin S Inhibitors

Reversible Inhibitors

Triazole Compounds

Anti-Inflammatory Agents

Naphthyridines

Benzothiophene Compounds

278 patents: Sort by Forward Citations

1. 12742022 - BINDING MOLECULES FOR THE TREATMENT OF CANCER (2026-09-22),

2. 12624397 - BIOMARKERS ASSOCIATED WITH ANTI-IL-36R ANTIBODY TREATMENT IN GENERALIZED PUSTULAR PSORIASIS (2026-05-12),

3. 11359023 - Antibodies targeting a complex comprising non-classical HLA-I and neoantigen and their methods of use (2022-06-14),

4. 8741897 - Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof (2014-06-03),

5. 8420630 - Pyrimidine derivatives (2013-04-16),

6. 8212040 - Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof (2012-07-03),

7. 8168752 - T cell proteins and nucleotides encoding the same (2012-05-01),

8. 8088915 - Methods for modulating IKKα activity (2012-01-03),

9. 7951933 - CD38 splice variants and uses thereof (2011-05-31),

10. 7932392 - Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof (2011-04-26),

11. 7914770 - Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants (2011-03-29),

12. 7795272 - Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof (2010-09-14),

13. 7790712 - Substituted [1,4]diazepino[1,2-A]indoles and azepino[1,2-A]indoles as anti-cytokine inhibitors (2010-09-07),

14. 7741361 - Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof (2010-06-22),

15. 7714127 - Process for making heteroaryl amine intermediate compounds (2010-05-11),

Company Overview

Boehringer Ingelheim Pharmaceuticals, Inc., headquartered in Ridgefield, CT, specializes in the development and manufacturing of innovative therapeutics, particularly in the field of cytokine inhibitors. The company focuses on advanced technologies such as glucocorticoid mimetics, pyrimidine derivatives, and antibodies, contributing to significant advancements in medical treatments. Their research encompasses various core technology topics, including stereoselective synthesis, fluorescent probes, and reversible inhibitors, aimed at addressing complex health challenges.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

278 Patents

#1 in Ridgefield, CT

#45 in Connecticut

#1,570 in US

#3,185 in the World

Ridgefield, CT, United States of America

Boehringer Ingelheim Pharmaceuticals, Inc.

Forward Citations = 3,802

312 inventors:

Eugene R Hickey (35 out of 66 patents)

John Robert Proudfoot (32 out of 38 patents)

David S Thomson (32 out of 46 patents)

4. Pier Francesco Cirillo (26 out of 33 patents)

5. Denice Mary Spero (24 out of 24 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Boehringer Ingelheim Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/boehringer-ingelheim-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…